SEC Form 4 · accession 0001493152-17-000411
LIXTE BIOTECHNOLOGY HOLDINGS, INC. · NMAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gil Schwartzberg
10% Owner
Period of report
Jan 11, 2017
Accepted (ET)
Jan 12, 2017 · 5:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001335105
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Jan 11, 2017 | P | 1,005,556 | $0.059 | A | 9,133,539 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were acquired by The Gil & Debbie Schwartzberg Family Trust dated November 19, 2003, Gil N. Schwartzberg Separate Property.